Literature DB >> 14612516

Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix.

Robert D Burk1, Masanori Terai, Patti E Gravitt, Louise A Brinton, Robert J Kurman, Willard A Barnes, Mitchell D Greenberg, Olympia C Hadjimichael, Leiping Fu, Larry McGowan, Rodrigue Mortel, Peter E Schwartz, Allan Hildesheim.   

Abstract

The distributions of human papillomavirus (HPV) types detected in cervical adenocarcinomas and squamous cell tumors differ. However, whether the distributions of intratypic HPV variants seen in these two histological forms of cervical disease differ is unknown. Our objective was to compare the distribution of HPV intratypic variants observed in squamous cell carcinomas (SCC) and cervical tumors of glandular origin (e.g., adenocarcinomas; AC) for two HPV types commonly observed in cervical tumors, HPV16 and HPV18. Participants in a multicenter case-control study of AC and SCC conducted in the eastern United States were studied. A total of 85 HPV16 and/or HPV18 positive individuals (31 diagnosed with AC, 43 diagnosed with SCC, and 11 population controls) were included. For HPV16-positive individuals, both the noncoding long control region and the E6 open reading frame were sequenced, and classified into phylogenetic-based lineage groups (European, Asian-American, African1, and African2). For HPV18-positive individuals, the long control region region only was sequenced and classified into known intratypic lineages (European, Asian-Amerindian, and African). The distribution of these different intratypic lineages among AC cases, SCC cases, and population controls was compared using standard methods. Non-European HPV16 and/or HPV18 intratypic variants were observed in 42% of ACs compared with 16% of SCCs and 18% of population controls (P = 0.04). Intratypic variants from the Asian-American lineage of HPV16 accounted for the differences seen between histological groups. The differences observed between AC and SCC cases were strongest for HPV16, and persisted in analysis restricted to Caucasian women, suggesting that the effect cannot be explained by differences in the ethnic make-up of AC versus SCC cases. Cervical AC and SCC differ not only with respect to the distribution of HPV types detected but also with respect to intratypic variants observed. Non-European HPV16 and/or HPV18 variants are commonly seen in AC. A possible hormonal mechanism is suggested to explain the observed findings.

Entities:  

Mesh:

Year:  2003        PMID: 14612516

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  51 in total

Review 1.  Human papillomavirus genome variants.

Authors:  Robert D Burk; Ariana Harari; Zigui Chen
Journal:  Virology       Date:  2013-08-31       Impact factor: 3.616

2.  Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population.

Authors:  Rosemary E Zuna; William E Moore; Rebecca P Shanesmith; S Terence Dunn; Sophia S Wang; Mark Schiffman; Gregory L Blakey; Travis Teel
Journal:  Int J Cancer       Date:  2009-12-01       Impact factor: 7.396

3.  Phylogenetic incongruence among oncogenic genital alpha human papillomaviruses.

Authors:  Apurva Narechania; Zigui Chen; Rob DeSalle; Robert D Burk
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  High-grade cervical lesions among women attending a reference clinic in Brazil: associated factors and comparison among screening methods.

Authors:  Neide T Boldrini; Luciana B Freitas; Amanda R Coutinho; Flavia Z Loureiro; Liliana C Spano; Angélica E Miranda
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

5.  Human papillomavirus genomics: past, present and future.

Authors:  Ariana Harari; Zigui Chen; Robert D Burk
Journal:  Curr Probl Dermatol       Date:  2014-03-13

6.  HPV16 variant lineage, clinical stage, and survival in women with invasive cervical cancer.

Authors:  Rosemary E Zuna; Erin Tuller; Nicolas Wentzensen; Cara Mathews; Richard A Allen; Rebecca Shanesmith; S Terence Dunn; Michael A Gold; Sophia S Wang; Joan Walker; Mark Schiffman
Journal:  Infect Agent Cancer       Date:  2011-10-28       Impact factor: 2.965

7.  CD83 polymorphisms and cervical cancer risk.

Authors:  Kelly J Yu; Janet S Rader; Ingrid Borecki; Zhengyan Zhang; Allan Hildesheim
Journal:  Gynecol Oncol       Date:  2009-05-15       Impact factor: 5.482

8.  Establishment and characterization of a novel head and neck squamous cell carcinoma cell line USC-HN1.

Authors:  Daniel J Liebertz; Melissa G Lechner; Rizwan Masood; Uttam K Sinha; Jing Han; Raj K Puri; Adrian J Correa; Alan L Epstein
Journal:  Head Neck Oncol       Date:  2010-02-22

9.  Is HPV-18 present in human breast cancer cell lines?

Authors:  I Peran; A Riegel; Y Dai; R Schlegel; X Liu
Journal:  Br J Cancer       Date:  2010-04-20       Impact factor: 7.640

10.  HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women.

Authors:  Lisa Mirabello; Meredith Yeager; Michael Cullen; Joseph F Boland; Zigui Chen; Nicolas Wentzensen; Xijun Zhang; Kai Yu; Qi Yang; Jason Mitchell; David Roberson; Sara Bass; Yanzi Xiao; Laurie Burdett; Tina Raine-Bennett; Thomas Lorey; Philip E Castle; Robert D Burk; Mark Schiffman
Journal:  J Natl Cancer Inst       Date:  2016-04-29       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.